MSB 3.61% $1.01 mesoblast limited

How come nobody discuses new fda regulatory trial endpoints that...

  1. 189 Posts.
    lightbulb Created with Sketch. 133
    How come nobody discuses new fda regulatory trial endpoints that are being allowed on ongoing cell therapy clinical trials.
    No need for placebo control if it looks like obvious efficacy. Use of real world data. Its actually a game changer in the business because clinical trials will be much cheaper. Anyway one of you smart guys should elaborate on the new guidance coming forward
    Cheers friends
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
0.035(3.61%)
Mkt cap ! $1.107B
Open High Low Value Volume
99.5¢ $1.01 99.0¢ $851.1K 849.8K

Buyers (Bids)

No. Vol. Price($)
17 40083 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.01 112380 13
View Market Depth
Last trade - 10.49am 04/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.